Last updated: October 7, 2026
Sebaceous hyperplasia is a harmless enlarged oil gland that usually looks like a small, yellowish bump with a dimple in the centre, and several often appear together on the forehead or cheeks. Basal cell carcinoma is a skin cancer that typically shows up as a single pearly or pink bump with visible tiny blood vessels, and it can bleed, crust, or slowly grow over months. A bump that bleeds, grows, or will not heal needs a professional exam and, in many cases, a skin biopsy to confirm what it actually is.
Basal cell carcinoma is a type of skin cancer arising from basal cells in the epidermis, while sebaceous hyperplasia is a non-cancerous enlargement of oil-producing (sebaceous) glands. The two conditions can look similar at a glance because both often appear as small, shiny bumps on the face, but they come from different tissue, behave differently over time, and carry very different health implications.
Basal cell carcinoma is the most common form of skin cancer worldwide and develops from abnormal growth of basal cells in the skin's outer layer [1]. It most often appears on sun-exposed areas like the nose, cheeks, forehead, and ears, and the nodular subtype typically presents as a pearly or translucent bump with visible surface blood vessels. Unlike sebaceous hyperplasia, BCC tends to slowly enlarge, and it can erode, bleed, or form a sore that does not heal properly. For a closer look at what this looks like in its earliest stages, see this guide on early-stage basal cell carcinoma.
Sebaceous hyperplasia is a benign overgrowth of normal sebaceous (oil) glands, most common in middle-aged and older adults with oilier skin types [4]. The bumps are usually soft, yellowish or skin-coloured, and frequently appear in clusters rather than alone, most often on the forehead, nose, and cheeks. They are considered a cosmetic finding with no cancer risk, though they are commonly mistaken for other facial growths on casual inspection.
The clearest distinguishing features are the number of bumps, the pattern of blood vessels, and whether the lesion bleeds or grows. A single, slowly growing, pearly bump with visible vessels points toward basal cell carcinoma, while multiple small, yellowish, stable bumps point toward sebaceous hyperplasia.
FeatureSebaceous HyperplasiaBasal Cell Carcinoma (nodular)ColourYellowish or skin-colouredPearly, pink, or translucentNumber of bumpsOften several, clusteredUsually solitaryCentral dip (umbilication)Common, central pore-like dimplePossible, but with a shiny, rolled borderBlood vesselsFine "crown vessels" around the rim [10]Irregular, branching (arborizing) telangiectasia [2]Bleeding or crustingRareCommon, especially after minor traumaGrowth over timeStable for yearsSlow but progressive growthCancer riskNoneRequires treatment; low metastasis risk but locally destructive [1]
A shiny bump that stays exactly the same for years is reassuring. One that slowly changes, bleeds, or scabs over repeatedly is not something to watch indefinitely.
Sebaceous hyperplasia appears as small, soft, yellowish or flesh-toned papules, usually 2 to 5 millimetres across, often with a tiny central dimple where the gland opens. The bumps form because sebaceous glands enlarge with age, a process linked to hormonal shifts and genetic predisposition rather than sun exposure [4].
Common features include:
Sebaceous hyperplasia and milia are both benign, but they come from different structures and look slightly different up close. Milia are tiny, firm, white or pale-yellow cysts formed from trapped keratin just under the skin surface, with no central pore and no vascular pattern, while sebaceous hyperplasia lesions are yellowish, slightly larger, and often show a visible central opening with surrounding fine vessels on close inspection or dermoscopy.
Early basal cell carcinoma often looks like a small, shiny, pink or pearly bump that someone might initially mistake for a pimple or an insect bite. The surface may show fine, branching blood vessels, and the lesion typically does not resolve the way a pimple would after a week or two.
Early signs to watch for:
People with fair skin, a history of significant sun or tanning bed exposure, older age, and a personal or family history of skin cancer carry higher risk for developing BCC [1][9]. Basal cell carcinoma typically develops slowly over months to years following cumulative UV damage, which is why lesions are sometimes present long before someone notices them. For a comparison with a condition that can look deceptively similar, this article on skin cancer that looks like a pimple is useful context.
Basal cell carcinoma does not turn into melanoma; the two cancers start from different cell types and follow separate biological pathways. BCC arises from basal cells, while melanoma arises from pigment-producing melanocytes, so one cannot transform into the other, though a person can develop both types of skin cancer independently over a lifetime [1]. A pigmented basal cell carcinoma can sometimes be mistaken for melanoma on visual inspection alone, which is one reason dermoscopy and biopsy matter; see this detailed comparison of pigmented BCC vs melanoma for more detail.
Sebaceous hyperplasia is not cancerous and does not carry a risk of turning into skin cancer. It is classified as a benign adnexal (gland-related) growth with no malignant potential on its own [4].
One exception worth noting factually: multiple or unusually extensive sebaceous lesions, particularly sebaceous adenomas rather than simple hyperplasia, can occasionally signal Muir-Torre syndrome, a rare hereditary condition linked to internal cancers [5][7]. This is uncommon and typically involves a pattern of multiple unusual sebaceous growths rather than the ordinary, isolated bumps most adults notice with aging skin. A clinician would consider this only when the presentation is atypical.
Doctors confirm the diagnosis using dermoscopy first, and a skin biopsy when the picture remains unclear or cancer cannot be ruled out visually. Dermoscopy is a handheld magnification tool that reveals vascular and structural patterns invisible to the naked eye, and it is the standard first step before any decision to biopsy.
Anyone curious about what the biopsy procedure itself involves can read this explanation of what a skin biopsy involves. A professional dermoscopy skin check in Toronto is the practical first step for anyone unsure about a facial bump.
A shiny or yellowish facial bump should be checked by a clinician if it bleeds, grows, changes shape, or fails to heal within a few weeks. Waiting for a suspicious lesion to resolve on its own, or attempting to remove it without professional assessment, risks missing an early, highly treatable skin cancer.
Red flags that warrant a prompt exam:
Attempting basal cell carcinoma removal at home is not safe. Picking, freezing, or squeezing a suspicious bump does not remove the underlying cancerous tissue, can delay proper diagnosis, and may cause scarring that complicates later treatment.
Basal cell carcinoma is treated through surgical removal, most commonly standard excision or Mohs surgery, because this reliably clears the cancerous tissue and confirms clear margins under the microscope. Sebaceous hyperplasia requires no treatment medically, though optional cosmetic procedures exist for people who want the bumps reduced in appearance.
Basal cell carcinoma treatment:
Sebaceous hyperplasia treatment:
The Minor Surgery Center assesses suspicious skin lesions without requiring a referral and removes basal cell carcinoma with OHIP coverage; details on the skin lesion assessment process in Toronto and on basal cell carcinoma care outline what an assessment involves.
Can sebaceous hyperplasia be mistaken for basal cell carcinoma?
Yes, both can appear as small, shiny, yellowish or pearly facial bumps, which is why dermoscopy or a skin biopsy is often needed to tell them apart confidently.
Does sebaceous hyperplasia go away on its own?
No, sebaceous hyperplasia is a permanent benign change in the gland and does not resolve without treatment, though it also does not require removal unless wanted for cosmetic reasons.
Is a bump with a central dimple always sebaceous hyperplasia?
No, nodular basal cell carcinoma can also show central depression or umbilication, so a central dip alone cannot confirm a benign diagnosis without further examination.
How fast does basal cell carcinoma grow?
Basal cell carcinoma typically grows slowly, often over many months to years, which is why early, subtle changes are easy to overlook until the lesion becomes more noticeable.
Can a biopsy be wrong?
A skin biopsy is the most reliable diagnostic tool available, and when combined with immunohistochemistry such as BerEP4 and EMA staining in ambiguous cases, it provides a highly accurate result [3].
Should every facial bump be biopsied?
No, not every facial bump needs a biopsy; a clinician typically uses dermoscopy first and reserves biopsy for lesions with features suspicious for basal cell carcinoma, such as bleeding, growth, or irregular vessels.
Sebaceous hyperplasia and basal cell carcinoma can look alike at first glance, but they differ in number, vessel pattern, bleeding behaviour, and long-term risk. A benign cluster of soft, yellowish bumps that has stayed the same for years is very different from a single pearly bump that slowly grows and occasionally bleeds. Because a photo or checklist cannot replace a clinical exam, anyone noticing a new, changing, or bleeding facial bump should book a professional skin assessment rather than guessing from an online comparison. The next practical step is a dermoscopy-based skin check, followed by a biopsy if the findings are unclear, so that treatment, if needed, can start without delay.
This article provides general information only and is not a medical diagnosis. Consult a qualified clinician for assessment of any skin lesion.
[1] Nbk562148 - https://www.ncbi.nlm.nih.gov/books/NBK562148/
[2] Pmc2805836 - https://pmc.ncbi.nlm.nih.gov/articles/PMC2805836/
[3] Pmc2128686 - https://pmc.ncbi.nlm.nih.gov/articles/PMC2128686/
[4] P601 - https://www.aafp.org/afp/2015/1001/p601
[5] Pmc1860623 - https://pmc.ncbi.nlm.nih.gov/articles/PMC1860623/
[6] Pmc12936259 - https://pmc.ncbi.nlm.nih.gov/articles/PMC12936259/
[7] Pmc4961504 - https://pmc.ncbi.nlm.nih.gov/articles/PMC4961504/
[9] P2175 - https://www.aafp.org/afp/2000/0401/p2175
[10] Csdm 5 4 - https://cosmoderma.org/content/130/2025/5/1/pdf/CSDM-5-4.pdf